VRNA vs. AVAV

Last updated Jun 9, 2026

VRNA (Verona Pharma plc) and AVAV (AeroVironment, Inc.) are both stocks. VRNA operates in Biotechnology (Healthcare), while AVAV operates in Aerospace & Defense (Industrials). At a 0.10 correlation, their price movements are largely independent.

Performance

VRNA vs. AVAV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and AeroVironment, Inc. (AVAV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

AVAV

• 1D: -0.67%
• 1M: 9.74%
• YTD: -23.65%
• 6M: -34.62%
• 1Y: -3.25%
• 3Y*: 23.54%
• 5Y*: 10.87%
• 10Y*: 19.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. AVAV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%
AVAV AeroVironment, Inc.	-23.65%	57.18%	22.10%	47.14%	38.09%	-28.62%	40.75%	-9.14%	20.99%	90.50%

Correlation

The correlation between VRNA and AVAV is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.10

The correlation between VRNA and AVAV shifts across timeframes, from -0.01 (1 year) to 0.13 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap VRNA : $9.72B AVAV : $9.01B
EPS VRNA : -$0.69 AVAV : -$4.63
PS Ratio VRNA : 57.97 AVAV : 7.51
PB Ratio VRNA : 34.92 AVAV : 2.11
Total Revenue (TTM) VRNA : $167.65M AVAV : $1.19B
Gross Profit (TTM) VRNA : $159.52M AVAV : $104.63M
EBITDA (TTM) VRNA : -$40.86M AVAV : -$242.06M

Return for Risk

VRNA vs. AVAV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVAV

AVAV Risk / Return Rank: 41
AVAV Sharpe Ratio Rank: 40
AVAV Sortino Ratio Rank: 43
AVAV Omega Ratio Rank: 42
AVAV Calmar Ratio Rank: 41
AVAV Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. AVAV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and AeroVironment, Inc. (AVAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VRNA	AVAV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.04	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.20	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.37	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.23	—

Drawdowns

Drawdown Indicators

	VRNA	AVAV	Difference
Max Drawdown Largest peak-to-trough decline	—	-61.45%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-61.45%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-61.45%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-61.45%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-61.45%	—
Current Drawdown Current decline from peak	—	-54.94%	—
Average Drawdown Average peak-to-trough decline	—	-28.56%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	33.68%	—

Volatility

Volatility by Period

	VRNA	AVAV	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	24.99%	—
Volatility (6M) Calculated over the trailing 6-month period	—	58.60%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	73.83%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	55.85%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	51.96%	—

Dividends

VRNA vs. AVAV - Dividend Comparison

Neither VRNA nor AVAV has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VRNA and AVAV in my portfolio?

VRNA and AVAV have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.